Posted By Kieran Beauchamp On 15 Dec 2025 Comments (10)
Market exclusivity extensions let pharmaceutical companies delay generic competition for years beyond patent expiration using FDA-granted protections like orphan drug status and pediatric extensions. Here's how they work-and why they're costing patients billions.
READ MORE